nach oben

Current Neurology and Neuroscience Reports

Erschienen in:

01.01.2017 | Neurology of Systemic Diseases (J Biller, Section Editor)

Systemic Complications Following Aneurysmal Subarachnoid Hemorrhage

verfasst von: Ravi Garg, Barak Bar

Erschienen in: Current Neurology and Neuroscience Reports | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Many systemic complications follow aneurysmal subarachnoid hemorrhage and are primarily due to sympathetic nervous system activation. These complications play an important role in the overall outcome of patients. The purpose of this review is to provide an update on the diagnosis, pathophysiology, and management of systemic complications specifically associated with aneurysmal subarachnoid hemorrhage. Special focus has been made on systemic complications that occur more frequently in patients with aneurysmal subarachnoid hemorrhage compared to other stroke subtypes and in the neurocritical care patient population. These complications include neurogenic pulmonary edema, electrocardiographic changes, troponin elevation, neurogenic stunned myocardium, hyponatremia, and anemia.

•• Diringer MN, Bleck T, Hemphill C, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–40. Print. Diringer et al. as part of the Neurocritical Care Society’s Multidisciplinary Consensus Conference reviewed the literature and provided evidence-based guidelines for the critical care management of patients following aneurysmal subarachnoid hemorrhage.

Chen S, Qian Li WH, Krafft PR, et al. The harmful effects of subarachnoid hemorrhage on extracerebral organs. Biomed Res Int. 2014;2014:1–12. Print.

Dhar R, Diringer MN. The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage. Neurocrit Care. 2008;8(3):404–12. Print.CrossRefPubMedPubMedCentral

Davison DL, Chawla LS, Selassie L, et al. Neurogenic pulmonary edema. Chest. 2012;141(3):793–5. Print.CrossRefPubMed

Muroi C, Keller M, Pangalu A, et al. Neurogenic pulmonary edema in patients with subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2008;20(3):188–92. Print.CrossRefPubMed

Friedman JA, Pichelmann MA, Piepgras DG, et al. Pulmonary complications of aneurysmal subarachnoid hemorrhage. Neurosurgery. 2003;52(5):1025–32. Print.PubMed

Davison DL, Terek M, Chawla LS. Neurogenic pulmonary edema. Crit Care. 2012;16(2):212. Print.CrossRefPubMedPubMedCentral

Fontes RB, Aguiar PH, Zanetti MV, et al. Acute neurogenic pulmonary edema: case reports and literature review. J Neurosurg Anesthesiol. 2003;15(2):144–50. Print.CrossRefPubMed

Sakr YL, Ghosn I, Vincent JL. Cardiac manifestations after subarachnoid hemorrhage: a systematic review of the literature. Prog Cardiovasc Dis. 2002;45(1):67–80. Print.CrossRefPubMed

10.

Goldfinger JZ, Nair A, Sealove BA. Brain-heart interaction in takotsubo cardiomyopathy. Heart Fail Clin. 2013;9(2):217–23. Print.CrossRefPubMed

11.

Lee VH, Oh JH, Mulvagh SL, Wijdicks E. Mechanisms in neurogenic stress cardiomyopathy after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2006;5(3):243–9. Print.CrossRefPubMed

12.

Parekh N, Venkatesh B, Cross D, et al. Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage. J Am Coll Cardiol. 2000;36(4):1328–35. Print.CrossRefPubMed

13.

Chatterjee S. ECG changes in subarachnoid haemorrhage: a synopsis. Neth Hear J. 2010;19(1):31–4. Print.CrossRef

14.

Tung P. Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke. 2004;35(2):548–51. Print.CrossRefPubMed

15.

Naidech AM. Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation. 2005;112(18):2851–6. Print.CrossRefPubMed

16.

Abd TT, Hayek S, Cheng J, et al. Incidence and clinical characteristics of takotsubo cardiomyopathy post-aneurysmal subarachnoid hemorrhage. Int J Cardiol. 2014;176(3):1362–4. Print.CrossRefPubMed

17.

• Bulsara KR, Mcgirt MJ, Liao L, et al. Use of the peak troponin value to differentiate myocardial infarction from reversible neurogenic left ventricular dysfunction associated with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2003;98(3):524–8. Print. Bulsara et al. retrospectively reviewed 350 patients with aneurysmal subarachnoid hemorrhage and proposed new criteria to differentiate neurogenic stunned myocardium from acute myocardial infarction.

18.

Kurisu S, Kihara Y. Tako-tsubo cardiomyopathy: clinical presentation and underlying mechanism. J Cardiol. 2012;60(6):429–37. Print.CrossRefPubMed

19.

Ancona F, Bertoldi LF, Ruggieri F, et al. Takotsubo cardiomyopathy and neurogenic stunned myocardium: similar albeit different: table 1. Eur Heart J. 2016. Print.

20.

Yee AH, Burns JD, Wijdicks E. Cerebral salt wasting: pathophysiology, diagnosis, and treatment. Neurosurg Clin N Am. 2010;21(2):339–52. Print.CrossRefPubMed

21.

Mcgirt MJ, Blessing R, Nimjee SM, et al. Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage. Neurosurgery. 2004;54(6):1369–74. Print.CrossRefPubMed

22.

Mapa B, Taylor BE, Appelboom G, et al. Impact of hyponatremia on morbidity, mortality, and complications after aneurysmal subarachnoid hemorrhage: a systematic review. World Neurosurg. 2016;85:305–14. Print.CrossRefPubMed

23.

Marik PE. Techniques for assessment of intravascular volume in critically ill patients. J Intensive Care Med. 2009;24(5):329–37. Print.CrossRefPubMed

24.

Moretti R, Pizzi B. Inferior vena cava distensibility as a predictor of fluid responsiveness in patients with subarachnoid hemorrhage. Neurocrit Care. 2010;13(1):3–9. Print.CrossRefPubMed

25.

Filippatos TD, Liamis G, Christopoulou F, Elisaf MS. Ten common pitfalls in the evaluation of patients with hyponatremia. Eur J Intern Med. 2016;29:22–5. Print.CrossRefPubMed

26.

Maesaka JK, Miyawaki N, Palaia T, et al. Renal salt wasting without cerebral disease: diagnostic value of urate determinations in hyponatremia. Kidney Int. 2007;71(8):822–6. Print.CrossRefPubMed

27.

Palmer BF. Hyponatremia in patients with central nervous system disease: SIADH versus CSW. Trends Endocrinol Metab. 2003;14(4):182–7. Print.CrossRefPubMed

28.

• Maesaka JK, Imbriano L, Mattana J, et al. Differentiating SIADH from cerebral/renal salt wasting: failure of the volume approach and need for a new approach to hyponatremia. J Clin Med. 2014;3(4):1373–85. Print. Maesaka et al. reviewed the differences between cerebral salt wasting and SIADH, highlighted the pitfalls of previous diagnostic approaches, and proposed a new volume independent algorithm for the evaluation of hyponatremia.

29.

Pierrakos C, Taccone F, Decaux G, et al. Urea for treatment of acute SIADH in patients with subarachnoid hemorrhage: a single-center experience. Ann Intensive Care. 2012;2(1):13. Print.CrossRefPubMedPubMedCentral

30.

Sterns RH, Silver SM. Cerebral salt wasting versus SIADH: what difference? J Am Soc Nephrol. 2008;19(2):194–6. Print.CrossRefPubMed

31.

Naidech AM, Jovanovic B, Wartenberg KE, Parra A, et al. Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage*. Crit Care Med. 2007;35(10):2383–9. Print.CrossRefPubMed

32.

• Roux PDL. Anemia and transfusion after subarachnoid hemorrhage. Neurocrit Care. 2011;15(2):342–53. Print. Roux et al. reviewed 27 articles about the effects of red blood cell transfusion in patients with aneurysmal subarachnoid hemorrhage. Most of the articles were very low quality according to the GRADE criteria. The authors concluded that it is not clear if red blood cell transfusion is a marker of disease severity or independent risk factor for worse outcome.

33.

Stein M, Brokmeier L, Herrmann J, Scharbrodt W, et al. Mean hemoglobin concentration after acute subarachnoid hemorrhage and the relation to outcome, mortality, vasospasm, and brain infarction. J Clin Neurosci. 2015;22(3):530–4. Print.CrossRefPubMed

34.

Dhar R, Zazulia AR, Videen TO, et al. Red blood cell transfusion increases cerebral oxygen delivery in anemic patients with subarachnoid hemorrhage. Stroke. 2009;40(9):3039–44. Print.CrossRefPubMedPubMedCentral

35.

Smith MJ, Roux PD, Elliott JP, Winn HR. Blood transfusion and increased risk for vasospasm and poor outcome after subarachnoid hemorrhage. J Neurosurg. 2004;101(1):1–7. Print.CrossRefPubMed

36.

Kurtz P, Helbok R, Claassen JJ, et al. The effect of packed red blood cell transfusion on cerebral oxygenation and metabolism after subarachnoid hemorrhage. Neurocrit Care. 2015;24(1):118–21. Print.CrossRef

37.

Larsen CC, Astrup J. Rebleeding after aneurysmal subarachnoid hemorrhage: a literature review. World Neurosurg. 2013;79(2):307–12. Print.CrossRefPubMed

Titel: Systemic Complications Following Aneurysmal Subarachnoid Hemorrhage
verfasst von: Ravi Garg
Barak Bar
Publikationsdatum: 01.01.2017
Verlag: Springer US
Erschienen in: Current Neurology and Neuroscience Reports / Ausgabe 1/2017
Print ISSN: 1528-4042
Elektronische ISSN: 1534-6293
DOI: https://doi.org/10.1007/s11910-017-0716-3

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

25.04.2024 | Hypotonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Systemic Complications Following Aneurysmal Subarachnoid Hemorrhage

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Frühe Alzheimertherapie lohnt sich

Viel Bewegung in der Parkinsonforschung

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2017

Clinical Relevance of Steroid Use in Neuro-Oncology

Brain Calcification and Movement Disorders

Autoimmune Movement Disorders: a Clinical and Laboratory Approach

Integrating Patient Concerns into Parkinson’s Disease Management

Systemic Complications of Spinal Cord Injury

Hyperkinetic Movement Disorder Emergencies

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Frühe Alzheimertherapie lohnt sich

Viel Bewegung in der Parkinsonforschung

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Neurologie